Searchable abstracts of presentations at key conferences in endocrinology

ea0016oc6.5 | Metabolism and cardiovascular | ECE2008

Association of the SHBG gene promoter polymorphism with early markers of atherosclerosis in apparently healthy women

Saltiki Katerina , Voidonikola Paraskevi , Lazaros Leandros , Stamatelopoulos Kimon , Mantzou Emily , Georgiou Ioannis , Anastasiou Eleni , Papamichael Christos , Alevizaki Maria

Objective: Androgen may be detrimental in the development of cardiovascular disease in women. We investigated possible associations between the (TAAAA)n polymorphism of sex hormone binding globulin (SHBG) gene promoter, which influences transcriptional efficiency of the SHBG gene and thus the tissue androgen availability and early markers of atherosclerosis in apparently healthy women.Design and methods: In this prospective clinical study, 153 con...

ea0016p39 | Adrenal | ECE2008

Impaired endothelial morphology and function in patients with subclinical Cushing's syndrome due to single adrenocortical adenomas

Androulakis Ioannis , Kollias Georgios , Markou Athina , Gouli Aggeliki , Anagnostou Tilemachos , Stamatelopoulos Kimon , Papamichael Christos , Piaditis Georgios , Kaltsas Gregory

Background: Subclinical Cushing’s syndrome (SCS) due to incidentally discovered adrenal adenomas (AI) has been associated with increased prevalence of hypertension, obesity, and impaired glucose tolerance which are established risk factors for cardiovascular morbidity. Although functional and morphological (structural) changes of endothelium have been correlated with cardiovascular morbidity this has not been looked into detail in patients with adrenal incidentalomas....

ea0014p487 | (1) | ECE2007

Study of aldosterone secretion in patients with essential hypertension using a modified suppression test

Gouli Aggeliki , Androulakis Ioannis , Markou Athina , Ragkou Despoina , Dimitriou Konstantina , Stathopoulou Alexandra , Anagnostou Tilemachos , Kondyli Georgia , Piaditis George

Background: The renin-angiotensin system is important for blood pressure control. Screening and diagnostic tests used so far to diagnose patients with aldosterone related hypertension does not take into consideration the stimulating ACTH effect on aldosterone secretion.Objective: To assess the role of aldosterone in essential hypertension using a modified suppression test, performed under suppressed ACTH levels.Subjects and methods...

ea0014p587 | (1) | ECE2007

Secondary hypothalamic amenorrhea as the initial manifestation of HIV infection

Tzifa Garyfallia , Kalikakis George , Zaganas Ioannis , Spiliotis Martha , Kofteridis Diamantis , Daraki Vasiliki , Petkova Valentina , Tzoutzouraki Paraskevi , Papavasileiou Stathis

Hypothalamic hormonal deficiency and anterior pituitary hormonal deficiency is a rare occurrence in patients presenting with HIV infection. We describe a patient with HIV infection who presented with secondary amenorrhea as the initial manifestation.Case report: A 34-year-old woman with previously regular menses presented with secondary amenorrhea by 9 months. The patient had mild gait instability for 7 months; anorexia and weight loss (10 kg) for the la...

ea0073pep8.4 | Presented ePosters 8: Pituitary and Neuroendocrinology | ECE2021

Whole exome sequencing (WES) reveals oligogenic aetiology in a case of combined pituitary hormone deficiency (CPHD)

Sertedaki Amalia , Tatsi Elizabeth , Vassilakis Ioannis Anargyros , Nikaina Eirini , Fylaktou Eirini , Iacovidou Nikoletta , Siahanidou Soultana , Kanaka-Gantenbein Christina

Background CPHD is characterized by GH and at least one other pituitary hormone deficiency. Mutations in genes expressed in the developing head, hypothalamus, and/or pituitary cause CPHD. To date around 30 genes have been identified to be related to CPHD, however 85% of the cases remain with unknown molecular aetiology.Patient and methodsA newborn boy (46, XY) delivered by CS due to IUGR with a birthweight of...

ea0073aep87 | Calcium and Bone | ECE2021

Effect of parathyroidectomy on early diastolic dysfunction assessed with ventricular mass index in patients with primary hyperparathyroidism

Tzikos Georgios , Manani Christina , Chorti Aggeliki , Evaggelos Sykaras , Boura Evangelia , Adamidou Foteini , Pliakos Ioannis , Papavramidis Theodosios S.

IntroductionPrimary hyperparathyroidism (PHPT) is characterized by excessive secretion of parathyroid hormone (PTH) from one or more parathyroid glands. PTH has a central role in the regulation of calcium and phosphate and the classic disorder causes primarily hypercalcemia associated with renal and bone manifestations. Non-classical symptoms are also present including cardiovascular, gastrointestinal, psychiatric, neuro-cognitive disorders. Regarding ca...

ea0073aep127 | Calcium and Bone | ECE2021

Large parathyroid adenomas: unusual clinical characteristics

Anastasia-Konstantina Sakali , Bagias Christos , Thoda Pinelopi , Mparmpa Eleftheria , Pappa Dimitra , Georgiou Eleni , Gountios Ioannis , Tigas Stelios , Bargiota Alexandra

IntroductionThe differential diagnosis between benign and malignant parathyroid neoplasms may be challenging and should always be based on clinical and histological criteria. We are presenting a case series of three patients with clinical, biochemical and imaging findings supporting the presence of a malignant neoplasm but histological findings confirming the diagnosis of a parathyroid adenoma.Case 1A 24-year...

ea0073aep494 | Pituitary and Neuroendocrinology | ECE2021

Cabergoline treatment for non functioning pituitary macroadenomas

Pappa Dimitra , Thoda Pinelopi , Anastasia – Konstantina Sakali , Barmpa Eleftheria , Georgiou Eleni , Gountios Ioannis , Alexandra Bargiota

IntroductionCabergoline seems to be a promising and effective medical treatment for the more agressive Non Functioning Pituitary Adenomas (NFPAs) by reducing or keeping tumor’s size stable long-term. Here we present the experience of our centerMethodsWe studied 7 patients with NFPAs attending our clinic the last 10 years (median period 42 months, range 12 to 114 months), in whom cabergoline was started d...

ea0073aep823 | Late Breaking | ECE2021

A case of euglycaemic ketoacidosis and concomitant acute pancreatitis in a diabetic patient treated with SGLT2i and GLP-1RA

Moustaki Melpomeni , Kalogeris Nikolaos , Katsafyloudi Maria , Papanikola Nektaria , Rigana Maria , Spanou Loukia , Angelopoulos Theodoros , Kalantzis Ioannis , Vryonidou Andromahi

IntroductionGlucagon-like peptide 1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) are the two novel classes of anti-diabetic agents with compelling efficacy, in terms of glucose-lowering and cardio-renal protection. Euglycemic diabetic ketoacidosis (EDKA) is a serious rare adverse effect of SLT2i while the use of GLP-1RA has been scarcely linked with acute pancreatitis in humans.Case presentatio...

ea0081rc5.4 | Rapid Communications 5: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2022

Empagliflozin induces endocan expression and alleviates NAFLD through regulation of NF-κB pathway

Nasiri-Ansari Narjes , Kyriakopoulos Georgios , Kyrou Ioannis , Flessa Christina-Maria , Lianou Maria , Karapanagioti Angeliki , Kaltsas Gregory , Papavassiliou Athanasios G , Randeva Harpal S , Kassi Eva

Introduction: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disorders. Endocan is a novel molecule of endothelial dysfuction which is expressed in liver. SGLT2i have been reported to improve NAFLD through amelioration of inflammation. While there are contradictory results regarding the serum endocan levels in NAFLD patients, data regarding endocan expression in liver tissue are limited. Aim: Herein, we aimed to investigat...